tirzepatide vs semaglutide results Comparative safety and side effects

Phase 2 trials showed up to 20% weight loss sustained over 52 weeks

Gastrointestinal side effects are the most commonly reported adverse reactions with Wegovy, affecting a significant proportion of patients, particularly during the initial dose escalation phase

Neurology 92 , e2559e2570 (2019)

the deltoid, the vastus lateralis of the outer thigh, the ventrogluteal region) must be located correctly to avoid nerves and vessels

Sin este transporte, la grasa liberada no puede quemarse como energa

Food factors that release GLP-1, such as dietary peptides and non-nutrients, are seen as desirable to improve glucose tolerance